You’re using a public version of DrugPatentWatch with 5 free searches available | Register to unlock more free searches. CREATE FREE ACCOUNT

Last Updated: March 28, 2024

Claims for Patent: 6,146,852


✉ Email this page to a colleague

« Back to Dashboard


Summary for Patent: 6,146,852
Title: Production of human parathyroid hormone from microorganisms
Abstract:The invention provides recombinant plasmids containing in DNA sequences coding for human preproparathyroid hormone. The invention further provides microorganisms, for example E. coli, transformed by these plasmids. The invention also provides a plasmid for insertion into yeast and a transformed yeast in which the plasmid contains DNA coding for parathyroid hormone. Parathyroid hormone is then secreted by the transformed yeast. Further the invention provides alternate polypeptides having parathyroid hormone activity, including PTH analogs, fragments and extensions, and provides alternate leader sequences and secretion signal sequences which can be used in the present invention. Finally, there are provided methods for purification of the secreted PTH hormone and/or derivatives.
Inventor(s): Gautvik; Kaare M. (Oslo, NO), Alestrom; Peter (Sollihogda, NO), Oyen; Tordis Beate (Oslo, NO), Gabrielsen; Odd Stokke (Oslo, NO)
Assignee: NPS Allelix Corp. (Mississauga, CA)
Application Number:08/461,436
Patent Claims:1. A process for producing recombinant parathyroid hormone (PTH) (1-84) protein comprising the steps of:

(a) providing a yeast microorganism comprising:

(1) a DNA sequence encoding the Saccharomyces mating factor .alpha.1 leader sequence as a leader sequence, said leader sequence lacking a STE13 recognition site; and

(2) a DNA sequence encoding PTH (1-84) protein, wherein the DNA encoding the leader sequence and the DNA sequence encoding PTH (1-84) protein are operably linked;

(b) culturing said yeast microorganism to allow expression of said PTH (1-84) protein, thereby producing PTH (1-84), wherein the yeast microorganism cleaves the PTH (1-84) protein from the leader sequence upon secretion of the PTH (1-84) protein from the yeast microorganism; and

(c) purifying the resultant PTH (1-84) protein.

2. The process of claim 1, wherein the PTH (1-84) is human PTH (1-84).

3. The process of claim 2, wherein the microorganism comprises the plasmid pSS.alpha.UXPTH-.DELTA.EA.

4. The process of claim 3, wherein the yeast is Saccharomyces cerevisiae.

5. The process of claim 4, wherein the yeast is Saccharomyces cerevisiae strain BJ1991.

6. The process of claim 1, wherein the protein has a purity of greater than 95%.

7. A process for producing recombinant parathyroid hormone (PTH) (1-84) protein comprising the steps of:

(a) providing a yeast microorganism comprising:

(1) a first DNA sequence encoding the first nineteen amino acids of the Saccharomyces mating factor .alpha.1 as a leader sequence; and

(2) a second DNA sequence encoding PTH (1-84) protein,

wherein the DNA sequence encoding the leader sequence and the DNA sequence encoding PTH (1-84) protein are operably linked;

(b) culturing said yeast microorganism to allow expression of said PTH (1-84) protein, thereby producing PTH (1-84) protein, wherein the yeast microorganism cleaves the PTH (1-84) protein from the leader sequence upon secretion of the PTH (1-84) protein from the yeast microorganism; and

(c) purifying the resultant PTH (1-84) protein.

8. The process of claim 7, wherein the PTH is human PTH.

9. The process of claim 7, wherein the yeast is Saccharomyces cerevisiae.

10. The process of claim 9, wherein the yeast is Saccharomyces cerevisiae strain BJ1991.

11. The process of claim 7, wherein the protein has a purity of greater than 95%.

12. A process for producing recombinant parathyroid hormone (PTH) (1-84) protein comprising the steps of:

(a) providing a yeast microorganism comprising:

(1) a DNA encoding a leader sequence; and

(2) a second DNA sequence encoding a peptide that is a derivative of PTH (1-84) protein, wherein the cleavage site after the pair of basic amino acids at positions 25 and 26 of the derivative PTH (1-84) protein has been modified such that the hormone is excluded as a substrate for yscF protease, wherein the DNA encoding the leader sequence and the DNA sequence encoding PTH (1-84) protein are operably linked;

(b) culturing said yeast microorganism to allow expression of said PTH (1-84) protein derivative, thereby producing PTH (1-84) protein, wherein the yeast microorganism cleaves the PTH (1-84) protein from the leader sequence upon secretion of the PTH (1-84) protein from the yeast microorganism; and

(c) purifying the resultant PTH (1-84) protein.

13. The process of claim 12, wherein the PTH is human PTH.

14. The process of claim 13, wherein amino acid 26 of the human PTH (1-84) protein is modified from lysine to glutamine.

15. The process of claim 12, wherein the leader sequence is the DNA sequence encoding Saccharomyces mating factor .alpha.1.

16. The process of claim 15 comprising the expression plasmid pSS.alpha.UXPTH-.DELTA.EA/KQ.

17. The process of claim 12, wherein the yeast is Saccharomyces cerevisiae.

18. The process of claim 17, wherein the yeast is Saccharomyces cerevisiae strain BJ1991.

19. The process of claim 12, wherein the protein has a purity of greater than 95%.

20. A process for producing recombinant parathyroid hormone (PTH) (1-84) comprising the steps of:

(a) providing a yeast microorganism comprising:

(1) a DNA sequence encoding PTH (1-84) protein; and

(2) a second DNA sequence encoding a signal sequence, wherein the signal sequence has the following:

(i) a positively charged amino-terminal;

(ii) a hydrophobic core region; and

(iii) a polar COOH-terminal region,

wherein the signal DNA sequence and the DNA sequence encoding PTH (1-84) protein are operably linked;

(b) culturing said yeast microorganism to allow expression of said PTH (1-84) protein, thereby producing PTH (1-84) protein, wherein the yeast microorganism cleaves the PTH (1-84) protein from the signal sequence upon secretion of the PTH (1-84) protein from the yeast microorganism; and

(c) purifying the resultant PTH (1-84) protein.

21. The process of claim 20, wherein the PTH is human PTH.

22. The process of claim 20, wherein the yeast is Saccharomyces cerevisiae.

23. The process of claim 22, wherein the yeast is Saccharomyces cerevisiae strain BJ1991.

24. The process of claim 20, wherein the signal sequence is a peptide selected from the consisting of: (1) Met-Lys-Ala-Lys-Leu-Leu-Val-Leu-Leu-Thr-Ala-Phe-Val-Ala-Thr-Asp-Ala; (2) Met-Arg-Ser-Leu-Leu-Ile-Leu-Val-Leu-Cys-Phe-Leu-Pro-Leu-Ala-Leu-Gly; and (3) Met-Arg-Phe-Ser-Ile-Phe-Thr-Ala-Val-Leu-Phe-Ala-Ala-Ser-Ser-Ala-Leu-Ala.

25. The process of claim 20, wherein the protein has a purity of greater than 95%.

26. A process for producing recombinant parathyroid hormone (PTH) (1-84) protein comprising the steps of:

(a) providing a yeast microorganism comprising:

(1) a DNA sequence encoding PTH (1-84) protein; and

(2) a second DNA sequence encoding a functional signal sequence having the following sequence

Met-Asn-lie-Phe-Tyr-Ile-Phe-Leu-Phe-Leu-Ser-Phe-Val-Gln-Gly-Thr-Arg-Gly,

and wherein the DNA encoding the signal sequence and the DNA sequence encoding PTH (1-84) protein are operably linked;

(b) culturing said yeast microorganism to allow expression of said PTH (1-84) protein, thereby producing PTH (1-84) protein, wherein the yeast microorganism cleaves the PTH (1-84) protein from the signal sequence upon secretion of the PTH (1-84) protein from the yeast microorganism; and

(c) purifying the resultant PTH (1-84) protein.

27. The process of claim 26, wherein the PTH is human PTH.

28. The process of claim 26, wherein the yeast is Saccharomyces cerevisiae.

29. The process of claim 26, wherein the yeast is Saccharomyces cerevisiae strain BJ1991.

30. The process of claim 26, wherein the protein has a purity of greater than 95%.

Make Better Decisions: Try a trial or see plans & pricing

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. thinkBiotech performs no independent verification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.